Ovid Therapeutics annual meeting elects two directors, ratifies KPMG

Ovid Therapeutics Inc.

Annual meeting held June 9, 2022; 58.53% quorum (41,220,715 of 70,417,345 shares).
Kevin Fitzgerald elected: 23,339,939 for, 76,303 withheld; broker non-votes 17,804,473.
Bart Friedman elected: 17,204,205 for, 6,212,037 withheld; broker non-votes 17,804,473.
Ratification of KPMG as auditor for FY2022: 40,049,679 for, 1,157,936 against, 13,100 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.